日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Preclinical study and phase 2 trial of neoadjuvant pyrotinib combined with chemotherapy in luminal/HER2-low breast cancer: PILHLE-001 study

吡咯替尼联合化疗治疗管腔内/HER2-low乳腺癌的临床前研究及Ⅱ期临床试验：PILHLE-001研究

期刊:Cell Reports Medicine
影响因子:11.7
doi:10.1016/j.xcrm.2024.101807
Chang Gong, Yuan Xia, Yingying Zhu, Yaping Yang, Qun Lin, Qiang Liu, Wenqian Yang, Li Ling, Jiajie Zhong, Zhuxi Duan, Yunjie Zeng, Ziliang Cheng, Jun Shen, Yinduo Zeng, Louis Wing Cheong Chow, Erwei Song
肿瘤
乳腺癌
发表日期：2024
文献求助 收藏

Perceived Importance of Breast Cancer Risk Factors: A Survey on 386 Physicians in China

中国386名医生对乳腺癌风险因素重要性的认知调查

期刊:Asian Pacific Journal of Cancer Prevention
影响因子:
doi:10.31557/APJCP.2022.23.2.379
Chow, Louis Wing-Cheong; Fu, Pei-Fen; Guo, Lei; Hu, Xi-Chun; Jiang, Jun; Lie, Erich Ferdiansyah; Liu, Jian; Lu, Xiao-Hong; Lu, Yong-Kui; Ma, Hong-Min; Mo, Qin-Guo; Shi, Yan-Xia; Wang, Kun; Wang, Ming-Hao; Wang, Shu; Wang, Shu-Sen; Wang, Xian-Ming; Wang, Xiao-Jia; Wu, Hui-Jing; Yang, Hong-Jian; Yao, He-Rui; Zhang, Yi; Zhu, Li; On Behalf Of The Asian Institute Of Clinical Oncology Aico Expert Panel, -
神经科学
肿瘤
肿瘤免疫
乳腺癌
发表日期：2022
文献求助 收藏

Increased 5α-reductase type 2 expression in human breast carcinoma following aromatase inhibitor therapy: the correlation with decreased tumor cell proliferation

芳香化酶抑制剂治疗后，人乳腺癌中5α-还原酶2型表达增加：与肿瘤细胞增殖减少相关

期刊:Hormones & Cancer
影响因子:
doi:10.1007/s12672-010-0062-2
Chanplakorn, Niramol; Chanplakorn, Pongsthorn; Suzuki, Takashi; Ono, Katsuhiko; Wang, Lin; Chan, Monica S M; Wing, Loo; Yiu, Christopher C P; Chow, Louis Wing-Cheong; Sasano, Hironobu
肿瘤细胞
乳腺癌
肿瘤
细胞生物学
肿瘤免疫
发表日期：2011
文献求助 收藏